hapabapa/iStock Editorial through Getty Pictures
Novo Nordisk (NVO) (OTCPK:NONOF) introduced on Sunday that its standard weight reduction drug Wegovy resulted in additional than a 50% lower in severe coronary heart points akin to stroke in comparison with Eli Lilly’s (NYSE:LLY) competing drug
